168 related articles for article (PubMed ID: 29264504)
1. Ethnicity of Patients With Germline
Guan B; Welch JM; Vemulapalli M; Li Y; Ling H; Kebebew E; Simonds WF; Marx SJ; Agarwal SK
J Endocr Soc; 2017 May; 1(5):488-499. PubMed ID: 29264504
[TBL] [Abstract][Full Text] [Related]
2.
Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
[TBL] [Abstract][Full Text] [Related]
3. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
[TBL] [Abstract][Full Text] [Related]
4. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
6. Variant Tyr 394Ser in the
Tolkin L; Klein V; Frankel M; Altarescu G; Beeri R; Munter G
J Endocr Soc; 2023 Jun; 7(7):bvad086. PubMed ID: 37362385
[TBL] [Abstract][Full Text] [Related]
7. Whole exome sequencing in familial isolated primary hyperparathyroidism.
Cetani F; Pardi E; Aretini P; Saponaro F; Borsari S; Mazoni L; Apicella M; Civita P; La Ferla M; Caligo MA; Lessi F; Mazzanti CM; Torregossa L; Oppo A; Marcocci C
J Endocrinol Invest; 2020 Feb; 43(2):231-245. PubMed ID: 31486992
[TBL] [Abstract][Full Text] [Related]
8. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
[TBL] [Abstract][Full Text] [Related]
9. New Concepts About Familial Isolated Hyperparathyroidism.
Marx SJ
J Clin Endocrinol Metab; 2019 Sep; 104(9):4058-4066. PubMed ID: 30848815
[TBL] [Abstract][Full Text] [Related]
10. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
Park HS; Lee YH; Hong N; Won D; Rhee Y
Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
[TBL] [Abstract][Full Text] [Related]
11. Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients.
Song A; Yang Y; Wang Y; Liu S; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Endocr Pract; 2020 Oct; 26(10):1093-1104. PubMed ID: 33471711
[TBL] [Abstract][Full Text] [Related]
12. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E
Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698
[TBL] [Abstract][Full Text] [Related]
13. A Knock-In Mouse Model of the
Parekh VI; Brinster LR; Guan B; Simonds WF; Weinstein LS; Agarwal SK
J Endocr Soc; 2023 Oct; 7(11):bvad126. PubMed ID: 37885910
[TBL] [Abstract][Full Text] [Related]
14. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF
Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.
D'Agruma L; Coco M; Guarnieri V; Battista C; Canaff L; Salcuni AS; Corbetta S; Cetani F; Minisola S; Chiodini I; Eller-Vainicher C; Spada A; Marcocci C; Guglielmi G; Zini M; Clemente R; Wong BY; de Martino D; Scillitani A; Hendy GN; Cole DE
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2794-8. PubMed ID: 25279501
[TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
[TBL] [Abstract][Full Text] [Related]
17. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.
El Lakis M; Nockel P; Gaitanidis A; Guan B; Agarwal S; Welch J; Simonds WF; Weinstein L; Marx S; Nilubol N; Patel D; Merkel R; Tirosh A; Kebebew E
J Am Coll Surg; 2018 May; 226(5):933-938. PubMed ID: 29408534
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Pareja R; Muntean A; Arsentales V; Caixàs A; Rigla M
Front Endocrinol (Lausanne); 2023; 14():1244361. PubMed ID: 37810884
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
[TBL] [Abstract][Full Text] [Related]
20. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
